Evaxion A/S Announces Capital Increase and Amendment to Articles of Association

Evaxion A/S, a Danish biotechnology company, reported a capital increase through the sale of 1,018,000 American Depositary Shares (ADSs) at an average price of USD $4.3931 per ADS, resulting in total proceeds of approximately $4.3 million. The company also amended its Articles of Association to reflect this capital increase and the exercise of certain investor warrants, which led to additional share capital increases. The amendments were registered with the Danish Business Authority, and the updated Articles of Association are attached as Exhibit 1.1. This filing highlights the company's ongoing efforts to raise capital and manage its equity structure.